Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Polyherbacy Prompts Need For Physician’s Advice

25.07.2003


Two University of Iowa Health Care physicians are calling attention to the issue of polyherbacy, the excessive or inappropriate ingestion of herbs for the treatment or prevention of disease, especially in older patients.


Jose Ness, M.D., UI assistant professor (clinical) of internal medicine, and Nicole Nisly, M.D., associate professor (clinical) of internal medicine and director of the UI Complimentary and Alternative Medicine Clinic



Jose Ness, M.D., UI assistant professor (clinical) of internal medicine, and Nicole Nisly, M.D., associate professor (clinical) of internal medicine and director of the UI Complimentary and Alternative Medicine Clinic, published a letter on polyherbacy in the May issue of the Journal of Gerontology.

The physicians said that oftentimes patients take herbal supplements in conjunction with their regular medicine regimen. However, combining conventional medications with herbal supplements without first talking to your physician can lead to possible adverse interactions with medication or illness.


Prior to taking an herbal supplement, a patient should have established a treatment goal, researched reliable sources for herbal information and consulted with their physician or pharmacist about safety and efficacy of the herbs.

"Patients should always discuss with their primary physician any medication, herbal or conventional, they’re taking," Ness said. "Physicians can then find out about possible side effects and help prevent unexpected complications."

Patients should also talk to their physician or pharmacist about conventional treatment options that are available to ensure the proper and best treatment is given, Nisly said.

"A patient is more likely to begin taking herbal supplements if they do not see desired results from more conventional methods," Nisly said.

Herbal supplements should not be used by children or anyone who is pregnant, lactating or receiving chemotherapy, HIV treatment, transplant medications or anticoagulants, due to increased risk of adverse side effects.

Commonly used herbs include ginseng, ginkgo biloba, garlic, St. Johns Wort, aloe and Echinacea. Sea algae and licorice are commonly found in multi-ingredient supplements.

Possible side effects can include headache, abdominal pain, fatigue and nausea. More serious side effects can include excessive bleeding or interaction with other drugs, resulting in excessive or diminished drug function, Nisly said.

Each herb can come in several forms, each different enough to cause differing side effects. "It is important to remember that just as with other medications, it is possible to experience an allergic reaction to an herbal supplement," Ness said.

While serious herbal complications are not common, Ness noted, caution is a must. The sicker a patient is, the more likely he or she is to experience such adverse reactions.

Ness added that there is a lack of standardization in herbal manufacturing, which is not approved or regulated by the Food and Drug Administration. Some supplements are produced with quality control standards similar to drug production, but some are not. Concerns with misidentified herbs and contaminants need to be kept in mind by both consumers and health care professionals.

Reading bottle labels is a valuable resource for learning about a product. The more information a label provides about dosage, ingredients, company reputation and contact info, the better. Patients should look for single-herb supplements known for safety and efficacy from reliable manufacturers.

Doctors need to be informed about herbal uses, interactions and side effects, so they are best able to counsel patients on safe herbal use.

"Doctors need to remember to listen with an open mind when patients talk about their preferred method of treatment, or the patient might withhold information such as herbal use," Ness said.

Ness and Nisly agree that the most important thing to remember when beginning any medication is to talk honestly and openly with your primary physician, in order to ensure the best care and safest use possible.

Becky Soglin | University of Iowa
Further information:
http://www.uihealthcare.com

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>